Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Neuroscientists discover how associative memories are formed

Has the scent of freshly baked chocolate chip cookies ever taken you back to afternoons at your grandmother's house? Has an old song ever brought back memories of a first date? The ability to remember relationships between unrelated items (an odor and a location, a song and an event) is known as associative memory.

23 Sep 2021

Immune cells in the brain join together to break down toxic proteins more quickly

To break down toxic proteins more quickly, immune cells in the brain can join together to form networks when needed. This is shown by a joint study of the University of Bonn, the German Center for Neurodegenerative Diseases, and the Institut François Jacob in France.

23 Sep 2021

People with neurologic conditions more likely to have had adverse childhood experiences

Adults with neurologic conditions are more likely than the general population to have had adverse childhood experiences such as abuse, neglect or household dysfunction, according to a study published in the September 22, 2021, online issue of Neurology Clinical Practice, an official journal of the American Academy of Neurology.

22 Sep 2021

UMass Lowell researcher awarded $2.7 million NIH grant to shed light on Alzheimer's disease

The National Institutes of Health has awarded $2.7 million to a UMass Lowell researcher studying how Alzheimer's disease evolves.

22 Sep 2021

Pinning down Pin1: Potential COVID-19 therapy

In a recent study scientists have demonstrated that Pin1 is one of the key cellular molecules necessary for SARS-CoV-2 propagation.

22 Sep 2021

MIND diet may benefit older adults, research shows

Aging takes a toll on the body and on the mind. For example, the tissue of aging human brains sometimes develops abnormal clumps of proteins that are the hallmark of Alzheimer's disease.

22 Sep 2021

Study investigates if music can improve memory in people with Alzheimer's disease

The main goal of the study, named "The Mozart Effect and memory in patients with cognitive impairment (MEM-COG)", is to investigate whether music can be used to facilitate or enhance learning in those with mild cognitive impairment (MCI) or mild Alzheimer's disease (AD).

21 Sep 2021

Researchers pioneer simple but revolutionary approach to early Alzheimer's diagnosis

A simple but revolutionary approach to early Alzheimer's diagnosis is being pioneered by researchers through an initiative that could pave the way for improved outcomes for individuals who develop the disease in the future.

21 Sep 2021

EIT Health highlights the urgent need for harnessing data and AI to fight against Alzheimer’s disease

To coincide with World Alzheimer’s Month, EIT Health, an EU-backed network of best-in-class health innovators, has highlighted the urgent need to focus on implementing bolder approaches to the treatment of Alzheimer’s Disease post-pandemic.

20 Sep 2021

Two-hour glucose tolerance test helps identify patients at heightened risk of cognitive decline

Diabetes is a risk factor for cognitive decline. In a study of the University of Turku and Finnish Institute for Health and Welfare, the researchers observed that already a higher two-hour glucose level in the glucose tolerance test predicts worse performance in a test measuring episodic memory after ten years.

18 Sep 2021

Brain scans can help estimate the time when a person will start showing signs of dementia

Researchers at Washington University School of Medicine in St. Louis have developed an approach to estimating when a person with no cognitive symptoms will start showing signs of Alzheimer's dementia based on data from brain scans and the person's age.

16 Sep 2021

UTSW researchers discover how vitamin A enters immune cells in the intestines

Immunologists and geneticists at UT Southwestern Medical Center have discovered how vitamin A enters immune cells in the intestines – findings that could offer insight to treat digestive diseases and perhaps help improve the efficacy of some vaccines.

16 Sep 2021

Novel cell reprogramming offers a promising therapeutic strategy to slow down glioblastomas

Gliomas are the most common primary brain tumors in adults. Among them, high-grade glioblastomas (GBMs) are particularly known to be notoriously aggressive and invasive, which makes it challenging to treat them. The disease rapidly progresses to an advanced stage in a short span of time, and the survival of such patients is often dismal.

16 Sep 2021

Research paves the way for advances in the treatment of many brain disorders

Bristol-led research has identified specific drug targets within the neural circuits that encode memories, paving the way for significant advances in the treatment of a broad spectrum of brain disorders.

16 Sep 2021

Study identifies probable cause of Alzheimer’s disease

Ground-breaking new Curtin University-led research has discovered a likely cause of Alzheimer's disease, in a significant finding that offers potential new prevention and treatment opportunities for Australia's second-leading cause of death.

16 Sep 2021

MS patients diagnosed with colorectal cancer may have shorter survival times, study finds

People with multiple sclerosis (MS) who are diagnosed with colorectal cancer may be at a higher risk of dying from cancer or other causes over the next six months to one year than people with colorectal cancer who do not have MS, according to a study published in the September 15, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.

16 Sep 2021

Alzheimer's Disease News and Research

Further Reading

Neuroscientists discover how associative memories are formed

Immune cells in the brain join together to break down toxic proteins more quickly

People with neurologic conditions more likely to have had adverse childhood experiences

UMass Lowell researcher awarded $2.7 million NIH grant to shed light on Alzheimer's disease

Pinning down Pin1: Potential COVID-19 therapy

MIND diet may benefit older adults, research shows

Study investigates if music can improve memory in people with Alzheimer's disease

Researchers pioneer simple but revolutionary approach to early Alzheimer's diagnosis

EIT Health highlights the urgent need for harnessing data and AI to fight against Alzheimer’s disease

Two-hour glucose tolerance test helps identify patients at heightened risk of cognitive decline

Brain scans can help estimate the time when a person will start showing signs of dementia

UTSW researchers discover how vitamin A enters immune cells in the intestines

Novel cell reprogramming offers a promising therapeutic strategy to slow down glioblastomas

Research paves the way for advances in the treatment of many brain disorders

Study identifies probable cause of Alzheimer’s disease

MS patients diagnosed with colorectal cancer may have shorter survival times, study finds

Scientists investigate if the APOE4 gene in astrocytes relates to Alzheimer's disease

Liver may play a key role in the onset or progression of Alzheimer's disease

Cholesterol appears to play a key role in the development of Alzheimer’s disease

Scientists identify a possible “Achilles’ heel” in the frustration of amyloid beta peptides

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News